← SynDRA
GSK-923295A
SynDRA canonical compound SYN0039855 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | CENPE |
| Mechanism of action | centromere associated protein inhibitor |
All known targets
Mechanisms of action (all sources)
- centromere associated protein inhibitor
- CENPE INHIBITOR
Cross-references
Synonyms
- GSK923295
- GSK-295
- GSK-923295
- GSK 923295
- 3-Chloro-N-((S)-1-(2-(dimethylamino)acetamido)-3-(4-(8-((S)-1-hydroxyethyl)imidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide
- 3-Chloro-N-((S)-1-(2-(dimethylamino)acetamido)-3-(4-(8-((S)-1-hydroxyethyl)-imidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide
- MLS006011170
- SCHEMBL1492164
- UNII-072702W9QD
- CTK8C0600
- DTXSID50677145
- AOB5937
- EX-A633
- MolPort-023-332-816
- BCP09858
- ANW-64945
- s7090
- ZINC68151184
- AKOS016005270
- GSK 923295A
- 3-Chloro-N-{(1S)-2-[(N,N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide
- 072702W9QD
- 3-chloro-N-[(2S)-1-[[2-(dimethylamino)acetyl]amino]-3-[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]propan-2-yl]-4-propan-2-yloxybenzamide
- CHEMBL4303470
- MFCD16038931
- NSC789041
- CCG-270165
- CS-0056
- NSC-789041
- NCGC00346943-01
- NCGC00346943-02
- AC-35919
- AS-56167
- Benzamide, 3-chloro-N-[(1S)-2-[[2-(dimethylamino)acetyl]amino]-1-[[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]methyl]ethyl]-4-(1-methylethoxy)-
- HY-10299
- SMR004702939
- SW208097-4
- J-690025
Look up GSK-923295A in the interactive SynDRA portal →